1003-3734
2013 Issue 1
..............page:13-16
ARMA model-based prediction analysis of industrial output of traditional Chinese patent medicine in "Twelfth Five-Year Plan" period in China
HOU Fu-ping1;LI Ye1;XU Jing1;ZHANG Hong2
HOU Fu-ping1;LI Ye1;XU Jing1;ZHANG Hong2
..............page:17-19
Main problems and analysis of additional specifications in the supplementary application
ZHANG Bao-zi1;TIAN Jie2;NING Li-li2
ZHANG Bao-zi1;TIAN Jie2;NING Li-li2
..............page:20-22
..............page:23-25,29
Synthesis of tivozanib hydrochloride monohydrate
FU Ying;ZHANG Qing-wen
FU Ying;ZHANG Qing-wen
..............page:26-29
Application of pharmacogenomics in clinical trials
ZHAO Nan1;2;ZHANG Ya-tong1;CHENG Gang2;HU Xin1
ZHAO Nan1;2;ZHANG Ya-tong1;CHENG Gang2;HU Xin1
..............page:30-33,99
Recent development in vaccine adjuvant research
ZHOU Yang;GENG Xing-chao;WANG Ju-feng;LI Bo
ZHOU Yang;GENG Xing-chao;WANG Ju-feng;LI Bo
..............page:34-42
Research progress of extracellular regulated protein kinase and its inhibitors
AI Jun-tao;HU Gao-yun;WANG Jing;LI Dai-hong;XIE Xin;LI Qian-bin
AI Jun-tao;HU Gao-yun;WANG Jing;LI Dai-hong;XIE Xin;LI Qian-bin
..............page:43-52
..............page:53-58
Pharmacology and clinical evaluation of indacaterol
WANG Dan-dan;SUN Tie-ying
WANG Dan-dan;SUN Tie-ying
..............page:1-3,22
Reflection on strategy and methods on trace unstable impurities of β-lactam antibiotics
HU Chang-qin1;JIANG Yu2;ZHANG Jing-pu3;ZHANG Zhe-feng2;LI Jin1; QIAN Jian-qin1;3;LI Ya-ping1;ZHANG Dou-sheng1
HU Chang-qin1;JIANG Yu2;ZHANG Jing-pu3;ZHANG Zhe-feng2;LI Jin1; QIAN Jian-qin1;3;LI Ya-ping1;ZHANG Dou-sheng1
..............page:4-12
Research progress of the therapeutic effects of fasudil,a Rho kinase inhibitor and its analogs,on central nervous system diseases
CHEN Mei-hui1;LIU An-min2;CHAO Xiao-juan1;PI Rong-biao1
CHEN Mei-hui1;LIU An-min2;CHAO Xiao-juan1;PI Rong-biao1
..............page:59-67
A phase Ⅰstudy to evaluate the clinical pharmacokinetics and pharmacodynamics of Y-pegylated recombinant human granulocyte-colony stimulating factor
SONG Yuan-yuan;SHI Yuan-kai;ZHANG Chun-ling;ZHOU Sheng-yu;YAO Jia-rui;GUI Lin; ZHANG Shu-xiang;TANG Le;LI Dan;WU Di;FENG Yun;HAN Xiao-hong
SONG Yuan-yuan;SHI Yuan-kai;ZHANG Chun-ling;ZHOU Sheng-yu;YAO Jia-rui;GUI Lin; ZHANG Shu-xiang;TANG Le;LI Dan;WU Di;FENG Yun;HAN Xiao-hong
..............page:68-74
..............page:123-125
Determination of dexketoprofen in human plasma by LC-MS
SONG Ying;JIA Yan-yan;GE Jie;LU Cheng-tao;LI Xue-qing; CHEN Min-chun;DING Yi;WEN Ai-dong
SONG Ying;JIA Yan-yan;GE Jie;LU Cheng-tao;LI Xue-qing; CHEN Min-chun;DING Yi;WEN Ai-dong
..............page:75-78
Effect of repaglinide on pitavastatin pharmacokinetics in healthy volunteers
WEN Jin-hua;WEI Xiao-hua;ZHENG Xue-lian;ZOU De-qin;HU Jin-fang;CAI Jun;LAI Yong-quan
WEN Jin-hua;WEI Xiao-hua;ZHENG Xue-lian;ZOU De-qin;HU Jin-fang;CAI Jun;LAI Yong-quan
..............page:79-82
..............page:126-128
Effect of clematichinenoside on abnormal lipid metabolism and atherosclerosis in rats
NIU Xiao-shu1;XIONG Jing2;BAI Li1;FANG Wei-rong1;LI Yun-man1
NIU Xiao-shu1;XIONG Jing2;BAI Li1;FANG Wei-rong1;LI Yun-man1
..............page:83-88
..............page:58
Determination of plasma protein binding of the caspase inhibitor F1013
WU Shan1;2;WEI Jun-xia2;WANG Qiong-qiong3;WU Jian-hong2;LIU Yan-wen1;ZENG Fan-dian3
WU Shan1;2;WEI Jun-xia2;WANG Qiong-qiong3;WU Jian-hong2;LIU Yan-wen1;ZENG Fan-dian3
..............page:89-92
..............page:82
Simultaneous determination of seven bioactive components of Ginkgo biloba L. in dog plasma by HPLC-MS/MS and its application in relative bioavailability of the tincture extract of Ginkgo biloba leaves
WU Cai-sheng;WANG Yi-lin;ZHANG Jin-lan;WANG Peng-yuan;HOU Jin-feng;NIU Chun-yan
WU Cai-sheng;WANG Yi-lin;ZHANG Jin-lan;WANG Peng-yuan;HOU Jin-feng;NIU Chun-yan
..............page:93-99
..............page:92
New synthetic route of doripenem
JIANG Yu-qin1;MA Jin-shuo1;XU Gui-qing1;WU Dou-can2;WANG Jun-qiang2;LI Wei1
JIANG Yu-qin1;MA Jin-shuo1;XU Gui-qing1;WU Dou-can2;WANG Jun-qiang2;LI Wei1
..............page:100-102,106
Determination of equilibrium solubility,apparent oil/water partition coefficient and dissociation constant of febuxostat
ZHANG Qi;GONG Yun;LAO Jia-yong;ZHANG Yi;LIU Zhong-qiu;CAI Zheng
ZHANG Qi;GONG Yun;LAO Jia-yong;ZHANG Yi;LIU Zhong-qiu;CAI Zheng
..............page:103-106
..............page:110
Preparation of pramipexole dihydrochloride sustained-release pellets and its released behavior in vitro
YUAN Zhong-wen;ZHOU Yu-bin;GUAN Shi-xia;ZHANG Yi;HU Bo;HE Feng-min
YUAN Zhong-wen;ZHOU Yu-bin;GUAN Shi-xia;ZHANG Yi;HU Bo;HE Feng-min
..............page:107-110
Determination of saccharide in Shuxuetong injection,hirudo and pheretima by HPLC with pre-column derivatization method
JIN Ying1;ZHANG Jin-lan1;JIA Zhi-xin1;CHEN Yan-ming2;WU Cai-sheng1
JIN Ying1;ZHANG Jin-lan1;JIA Zhi-xin1;CHEN Yan-ming2;WU Cai-sheng1
..............page:111-115,122
The participation of clinical pharmacist in exclusion of suspected statin-related drug eruption,a case report
WAN Bo1;ZHENG Ping2
WAN Bo1;ZHENG Ping2
..............page:116-119
Clinical pharmacists involved in one case consultation of a patient with refractory staphylococcal infection
QIAN Chun-yan;XIE Yun-fen;WANG Ming-li
QIAN Chun-yan;XIE Yun-fen;WANG Ming-li
..............page:120-122